Literature DB >> 22840937

Ameliorative effects of resveratrol on acute ovarian toxicity induced by total body irradiation in young adult rats.

Yavuz Simsek1, Simay Gurocak, Yusuf Turkoz, Nusret Akpolat, Onder Celik, Ali Ozer, Ercan Yılmaz, Ugur Turhan, Fatma Ozyalin.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the ovarian protective effects of resveratrol in rats exposed to total body irradiation.
DESIGN: Experimental study. SETTINGS: University hospital. PARTICIPANTS AND
INTERVENTIONS: Thirty female rats were randomized into four groups: (1) control group (n = 7); (2) low-dose (10 mg/kg) resveratrol group (n = 8); (3) high-dose (100 mg/kg) resveratrol group (n =7); and (4) sham irradiation group (n = 8). The drugs were administered intraperitoneally as single doses, and the rats were exposed to total body radiation 24 h after the treatment. The animals were sacrificed the following day, and their ovaries were excised for histopathological and biochemical analysis. MAIN OUTCOME MEASURES: The ovarian follicle counts were calculated, and irradiation-dependent ovarian damage and tissue levels of antioxidant enzymes were evaluated.
RESULTS: Group 2 and Group 3 showed significantly higher numbers of total follicle counts compared with Group 1 (P < 0.01). The low-dose resveratrol treatment was associated with significantly higher numbers of primary follicles than the high-dose group. The tissue activities of glutathione peroxidase (GsH-Px) and catalase (CAT) were significantly elevated in the resveratrol-treated animals. Evaluation of ovarian histology revealed no remarkable changes in fibrosis and leucocyte infiltration among the resveratrol-treated and control rats; however, vascularity was significantly reduced in the high-dose group (P = 0.014).
CONCLUSION: Resveratrol attenuated irradiation-dependent ovarian damage, suggesting that this natural antioxidant is effective in reducing the follicle loss induced by ionizing radiation.
Copyright © 2012 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22840937     DOI: 10.1016/j.jpag.2012.04.001

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   1.814


  6 in total

Review 1.  The Radioprotective Activity of Resveratrol-Metabolomic Point of View.

Authors:  Michalina Gramatyka
Journal:  Metabolites       Date:  2022-05-25

2.  Resveratrol protects the ovary against chromium-toxicity by enhancing endogenous antioxidant enzymes and inhibiting metabolic clearance of estradiol.

Authors:  Sakhila K Banu; Jone A Stanley; Kirthiram K Sivakumar; Joe A Arosh; Robert C Burghardt
Journal:  Toxicol Appl Pharmacol       Date:  2016-04-27       Impact factor: 4.219

3.  Resveratrol inhibits ionising irradiation-induced inflammation in MSCs by activating SIRT1 and limiting NLRP-3 inflammasome activation.

Authors:  Yue Fu; Yan Wang; Liqing Du; Chang Xu; Jia Cao; Tiqiang Fan; Jianxiang Liu; Xu Su; Saijun Fan; Qiang Liu; Feiyue Fan
Journal:  Int J Mol Sci       Date:  2013-07-08       Impact factor: 5.923

Review 4.  Reactive Oxygen Species Drive Epigenetic Changes in Radiation-Induced Fibrosis.

Authors:  Shashank Shrishrimal; Elizabeth A Kosmacek; Rebecca E Oberley-Deegan
Journal:  Oxid Med Cell Longev       Date:  2019-02-06       Impact factor: 6.543

5.  Manganese porphyrin, MnTE-2-PyP, treatment protects the prostate from radiation-induced fibrosis (RIF) by activating the NRF2 signaling pathway and enhancing SOD2 and sirtuin activity.

Authors:  Shashank Shrishrimal; Arpita Chatterjee; Elizabeth A Kosmacek; Paul J Davis; J Tyson McDonald; Rebecca E Oberley-Deegan
Journal:  Free Radic Biol Med       Date:  2020-03-25       Impact factor: 7.376

6.  Radioprotective and antioxidant effect of resveratrol in hippocampus by activating Sirt1.

Authors:  Jianguo Li; Li Feng; Yonghua Xing; Yan Wang; Liqing Du; Chang Xu; Jia Cao; Qin Wang; Saijun Fan; Qiang Liu; Feiyue Fan
Journal:  Int J Mol Sci       Date:  2014-04-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.